✦ LIBER ✦

Comparative pharmacodynamic evaluation of eptifibatide and tirofiban HCl in patients undergoing percutaneous coronary intervention (the TAM1 Study)

✍ Scribed by Jorge F Saucedo; Luis Garza; David C Wolford; Stephen L Cook; Kodangudi B Ramanathan; Zakaria Matin; Frank A McGrew; Mary V Jacoski; Lisa K Jennings

Book ID: 113440934
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 111 KB
Volume: 93
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2004.02.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of efficacy and safety of nat

Comparison of efficacy and safety of native eptifibatide vs. tirofiban in patients with acute coronary syndrome undergoing percutaneous coronary intervention

✍ Jianjin Tang; Liansheng Wang; Hui Wang; Mingwei Wang; Kejiang Cao; Zhijian Yang 📂 Article 📅 2008 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 132 KB

A comparative study of light transmissio

A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban

✍ Daniel I. Simon; Christopher B. Liu; Peter Ganz; James M. Kirshenbaum; Robert N. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

Comparative Pharmacodynamic Evaluation o

Comparative Pharmacodynamic Evaluation of Eptifibatide and Abciximab in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: The TAM2 Study

✍ Jorge F. Saucedo; Henry K. Lui; Luis Garza; G. Jose Guerra; Mary V. Jacoski; Lis 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 179 KB

Pharmacodynamics and pharmacokinetics of

Pharmacodynamics and pharmacokinetics of the platelet GPIIb/IIIa inhibitor tirofiban in patients undergoing percutaneous coronary intervention: implications for adjustment of tirofiban and clopidogrel dosage

✍ Carey Kimmelstiel; Jehangir Badar; Lidija Covic; Sergio Waxman; Andrew Weintraub 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 572 KB

Time course, magnitude, and consistency

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention

✍ Dean J Kereiakes; Thomas M Broderick; Eli M Roth; David Whang; Thomas Shimshak; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 454 KB

Inhibition of Platelet Aggregation With

Inhibition of Platelet Aggregation With Eptifibatide, Bivalirudin, and Heparin in Patients Undergoing Percutaneous Coronary Intervention Receiving Clopidogrel Pretreatment (The PharmacoDynamic Evaluation of Angiomax, Clopidogrel With Or Without INtegrilin [DEACON] Study)

✍ Jorge F. Saucedo; Wady Aude; Rebecca Pacheco; Brett Thorn; Zakaria Matin; Khawaj 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 137 KB